Business Description
Ekso Bionics Holdings Inc
NAICS : 339112
SIC : 3841
ISIN : US2826442020
Total Employee Number:
55Description
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.93 | |||||
Equity-to-Asset | 0.29 | |||||
Debt-to-Equity | 0.75 | |||||
Debt-to-EBITDA | -0.32 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -19.03 | |||||
Beneish M-Score | -3.82 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -29.3 | |||||
3-Year EBITDA Growth Rate | 37.1 | |||||
3-Year EPS without NRI Growth Rate | 32 | |||||
3-Year FCF Growth Rate | 34 | |||||
3-Year Book Growth Rate | -55.6 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 30.8 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.55 | |||||
Quick Ratio | 1.03 | |||||
Cash Ratio | 0.44 | |||||
Days Inventory | 333.33 | |||||
Days Sales Outstanding | 182.31 | |||||
Days Payable | 115.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -59.3 | |||||
Shareholder Yield % | 2.56 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 52.86 | |||||
Operating Margin % | -134.06 | |||||
Net Margin % | -135.66 | |||||
EBITDA Margin % | -118.11 | |||||
FCF Margin % | -105.16 | |||||
OCF Margin % | -103.62 | |||||
ROE % | -163.2 | |||||
ROA % | -70.09 | |||||
ROIC % | -107.77 | |||||
3-Year ROIIC % | 284.8 | |||||
ROC (Joel Greenblatt) % | -192.93 | |||||
ROCE % | -109.37 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 2.81 | |||||
PB Ratio | 19.85 | |||||
EV-to-EBIT | -3.02 | |||||
EV-to-EBITDA | -3.38 | |||||
EV-to-Revenue | 3.99 | |||||
EV-to-Forward-Revenue | 0.67 | |||||
EV-to-FCF | -3.81 | |||||
Price-to-GF-Value | 2.65 | |||||
Price-to-Median-PS-Value | 1.03 | |||||
Earnings Yield (Greenblatt) % | -33.11 | |||||
FCF Yield % | -28.86 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ekso Bionics Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 9.918 | ||
| EPS (TTM) (€) | -4.632 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.54 | ||
| 3-Year Sortino Ratio | -0.8 | ||
| Volatility % | 43.19 | ||
| 14-Day RSI | - | ||
| 14-Day ATR (€) | - | ||
| 20-Day SMA (€) | 3.315 | ||
| 12-1 Month Momentum % | -43.19 | ||
| 52-Week Range (€) | 3.074999 - 10.709999 | ||
| Shares Outstanding (Mil) | 3.56 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ekso Bionics Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ekso Bionics Holdings Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-10-28 | In 69 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-28 16:30 | 3.32 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2026-07-28 | 3.32 (+0.00%) | ||
| General meeting for 2026 | 2026-05-15 09:00 | 3.32 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-05 16:30 | 3.32 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-05 | 3.32 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-03 16:30 | 3.32 (+0.00%) | ||
| Annual report for 2025 | 2026-03-03 | 3.32 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-03 | 3.32 (+0.00%) | ||
| Third quarter earnings conference call for 2025 | 2025-10-29 16:30 | 3.32 (+0.00%) |
Show
Entries
Ekso Bionics Holdings Inc Frequently Asked Questions
What is Ekso Bionics Holdings Inc(FRA:23E0)'s stock price today?
The current price of FRA:23E0 is €3.32. The 52 week high of FRA:23E0 is €10.71 and 52 week low is €3.07.
When is next earnings date of Ekso Bionics Holdings Inc(FRA:23E0)?
The next earnings date of Ekso Bionics Holdings Inc(FRA:23E0) is 2026-10-28 Est..
Does Ekso Bionics Holdings Inc(FRA:23E0) pay dividends? If so, how much?
Ekso Bionics Holdings Inc(FRA:23E0) does not pay dividend.
Press Release
Articles on Ekso Bionics Holdings Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers